Form 8-K - Current report:
SEC Accession No. 0000950170-25-041254
Filing Date
2025-03-18
Accepted
2025-03-18 16:30:09
Documents
12
Period of Report
2025-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20250313.htm   iXBRL 8-K 53488
2 EX-10.1 crbp-ex10_1.htm EX-10.1 339022
  Complete submission text file 0000950170-25-041254.txt   559561

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20250313.xsd EX-101.SCH 31270
14 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20250313_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 25748860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)